Actions

CD79a: Difference between revisions

From haematologyetc.co.uk

(Created page with "<span style="color:navy">'''''DETAILS'''''</span> CD38 helps mobilise intracellular calcium to activate a wide array of cell functions. In haematological cell types CD38 it is widely expressed by lymphoid cells )B, T and NK) as well as myeloid precursor cells and mature myeloid cells. It has particular diagnostic importance for lymphocytes where CD38 expression is acquired as stem cells commit to B-cell lineage, then is lost as mature B cells emerge from bone marrow be...")
 
(Blanked the page)
Tag: Blanking
Line 1: Line 1:
<span style="color:navy">'''''DETAILS'''''</span>


CD38 helps mobilise intracellular calcium to activate a wide array of cell functions. In haematological cell types CD38 it is widely expressed by lymphoid cells )B, T and NK) as well as myeloid precursor cells and mature myeloid cells. It has particular diagnostic importance  for lymphocytes where CD38 expression is acquired as stem cells commit to B-cell lineage, then is lost as mature B cells emerge from bone marrow before being re-acquired at the time of plasma cell differentiation.
<span style="color:navy">'''What is its diagnostic role?'''</span>
The wide expression of CD38 limits its diagnostic value except in very specific circumstances:
*The co-expression of CD38 with CD138 can identify normal or neoplastic plasma cells
*Expression of CD38 in chronic lymphocytic leukaemia (>20% of cells) may associated with poorer outcome
<span style="color:navy">'''Other relevant information:'''</span> CD38 is a therapeutic target, daratumumab is a monoclonal antibody which binds to CD38 and is used in the treatment of myeloma.
----
<span style="color:navy">'''''SUMMARY TABLES'''''</span>
{| class=wikitable style="text-align: center; width: 800px;"
|-
!colspan="8"|Expression of CD38 by primitive lymphoid cells: ALL and haematogones
|-
! pro-B ALL !! early pre-B ALL !!pre-B ALL!! B-ALL !!pro-T ALL !!mature-T ALL !!AML !!Haematogones
|-
|style= "width: 100px; height: 20px; background: #006699; color:white"|
|style="width: 100px; background: #006699; color:white"|
|style="width: 100px; background: #006699; color:white"|
|style="width: 100px; background: #006699; color:white"|
|style="width: 100px; background: #006699; color:black"|
|style="width: 100px; background: #006699; color:black"|
|style="width: 100px; background: #00b8e6; color:white"|*
|style="width: 100px; background: #004466; color:white"|stg
|-
|}
<span style="font-size:80%">''* low expression correlates with subtype e.g. APML''</span>
{| class=wikitable style="text-align: center; width: 800px; height 20px;"
|-
!colspan="8"|Expression of CD38 by mature B cells: B-lymphoproliferative disorders
|-
! CLL !! MCL !!FL!! HCL !!HCv !!MZL!!LPL!!PCL
|-
|style= "width: 100px; background: #00b8e6; color:black"|*
|style="width: 100px; background: #004466; color:white"|
|style="width: 100px; background: #004466; color:white"|**
|style= "width: 100px; background: #00b8e6; color:white"|
|style= "width: 100px; background: #00b8e6; color:white"|
|style="width: 100px; background: #004466; color:white"|
|style="width: 100px; background: #006699; color:white"|
|style="width: 100px; background: #004466; color:white"|stg/mod
|-
|}
<span style="font-size:80%">''*May indicate adverse prognostic when present on more than 20% of cells''</span>
<span style="font-size:80%">''**May be weak''</span>
----

Revision as of 21:48, 8 May 2023